L-theanine, the amino acid best known from green tea, has one of the more consistent evidence bases among relaxation ingredients, and Japan has sold it in tea, drinks and supplements for decades. Brands abroad ask for it as a caffeine-free “calm” ingredient, often paired with GABA or glycine.
This guide is for brand owners planning an oral L-theanine product made in Japan. It covers what the trials show for stress and sleep, how Japan frames the ingredient, a regulatory point worth checking early if you plan to sell in the EU, and how to formulate the product.
Health supplements are foods, not medicines, and are not a substitute for medical treatment. Nothing here is a claim that any product prevents, treats or cures a disease.
💬 Planning an L-theanine product made in Japan? We check the full formula against Japanese food law first. See Japan-made supplement OEM.
What the research shows
A 2025 meta-analysis of 19 trials found L-theanine produced a real but modest improvement in subjective sleep quality, and a separate randomised trial reported lower stress-related and sleep scores at 200 mg a day — though the underlying trials are often small, mixed with other ingredients, or industry-funded.
| Study | Design/What was analysed | Reported result |
|---|---|---|
| Systematic review and meta-analysis, Sleep Medicine Reviews 2025 (PMID 40056718) | 19 randomised trials (897 participants, people of all ages and health status), 18 pooled | L-theanine significantly improved subjective sleep onset latency, subjective daytime dysfunction and overall subjective sleep quality score (small to moderate effect sizes); the authors note a lack of studies on L-theanine on its own |
| Randomised, double-blind, placebo-controlled cross-over trial, Nutrients 2019 (PMC6836118, PMID 31623400, DOI 10.3390/nu11102362) | 30 adults with no major psychiatric illness took 200 mg/day L-theanine or placebo tablets for 4 weeks each | Depression, trait-anxiety and Pittsburgh Sleep Quality Index scores decreased after L-theanine; sleep-latency and sleep-disturbance subscale scores fell more than with placebo; verbal fluency improved versus placebo in the subgroup with lower starting scores |
Caveats worth knowing:
- Subjective outcomes. The outcomes that improved in the 2025 meta-analysis were self-reported sleep measures — an important distinction to keep in any claim.
- Mixed formulations. The meta-analysis authors point to a lack of studies on L-theanine alone, which makes isolating its own effect harder.
- Funding. The 2019 Nutrients trial was funded by an L-theanine ingredient producer, and two authors were company employees.
- Mixed populations. The meta-analysis pooled people of all ages and health status, while the 2019 trial involved adults with no major psychiatric illness — neither result is a claim about any diagnosed condition.
Checked against the published abstracts on 25 September 2026.
What Japanese products say
L-theanine has been notified under Japan’s Foods with Function Claims system for functions describing support for a good night’s sleep and easing temporary, work-related stress, typically at 200 mg a day.
Under this system, the business that notifies the product is responsible for its own evidence, submitted to the Consumer Affairs Agency before sale. Japanese products in this category have included ready-to-drink teas and tablets, and the notified wording speaks of everyday tiredness and sleep quality, not any diagnosed condition.
Two lessons for a brand abroad:
- The Japanese wording stays modest. It describes temporary, everyday states at a stated 200 mg amount — not a guaranteed cure for poor sleep.
- A Japanese notification is a domestic mechanism. It applies to products sold in Japan. Your label abroad follows your own market’s rules, and L-theanine’s regulatory status differs by market — see the note below for one example.
💬 Need an evidence summary for your regulatory adviser that separates Japanese notifications from independent trials? We prepare it with the manufacturing documents. Tell us your market.
A regulatory note worth checking early: the EU
In the European Union, L-theanine’s status depends on how it is made, so confirm your material’s source before you commit to a formula.
L-theanine extracted from green tea (Camellia sinensis) and L-theanine made by chemical synthesis or microbial fermentation are not treated the same way under the EU’s novel food rules. If you plan to sell into the EU, confirm your material’s exact source and production method with your supplier and your own regulatory adviser.
Wording that stays on safe ground
Describe L-theanine by the amount studied and the subjective outcome measured, not by any diagnosed condition.
| Safer wording | Wording to avoid |
|---|---|
| ”Contains 200 mg L-theanine, the amount studied for sleep quality” | Names of sleep or anxiety disorders, or “cures insomnia" |
| "Studied for everyday stress and sleep quality" | "Clinically proven” without naming the study and its limits |
| Stating whether the material is green-tea-derived or synthesised/fermented | Leaving the production method unstated when selling into a market where it affects legal status |
How L-theanine is formulated
The studied amount sits around 200 mg a day, and L-theanine is water-soluble and stable, so it fits capsules, tablets, drinks and powder sticks equally well.
| Dosage form | Why brands choose it | What to weigh up |
|---|---|---|
| Hard capsule or tablet | Simple, precise dosing at 200 mg | Pairs easily with GABA or glycine in a “relax” formula |
| Drink or ready-to-drink tea | A familiar Japanese format for this ingredient | Taste and stability alongside other actives |
| Powder stick | Evening-routine products | Taste and dissolving |
Decisions that shape the specification:
- Source and production method. Green-tea-derived and synthetic/fermentation-derived L-theanine are treated differently under some markets’ rules — confirm which one you are being offered.
- Amount per serving. 200 mg is the amount used in the Japanese notifications and in the cited trial; match your claim to your dose.
- Companion ingredients. L-theanine is often combined with GABA, glycine or botanical extracts in relaxation formulas. Every companion needs its own check against Japanese food law — some botanicals sold freely elsewhere are treated as medicines in Japan.
- Your market’s status for L-theanine. Confirm it before you commit to a formula, particularly if you plan to sell in the EU.
The check that comes first
Every ingredient must be permitted in foods in Japan, or a Japanese factory cannot make the product.
L-theanine itself is widely used in Japanese foods. Relaxation and sleep formulas are where companion botanicals most often cause a problem. See the Japan-made supplement OEM page, and compare with our GABA and glycine guides if you plan a combined product.
Before you ask for a quotation
A factory can quote accurately once the source, the amount, the form and the companions are fixed.
- L-theanine source (green tea or synthesised/fermented) and specification
- Amount per serving and servings per pack
- Dosage form
- Companion ingredients and their amounts
- Packaging
- Countries you will sell in, and L-theanine’s status there
💬 Ready to design a Japan-made L-theanine product? Send us the concept — amount, form, companion ingredients and the countries you will sell in.
Frequently asked questions
1. Does L-theanine actually improve sleep?
A 2025 meta-analysis of 19 trials found real but modest improvements in subjective sleep onset, daytime function and overall sleep-quality scores — all self-reported measures. Describe it as studied for subjective sleep quality, not as a proven cure for poor sleep.
2. What dose is typically used?
200 mg a day is the amount used in both the Japanese Foods with Function Claims notifications and the 2019 randomised trial cited above.
3. Can I sell L-theanine everywhere, including the EU?
Not automatically. L-theanine from green tea is not treated as a novel food in the EU, but L-theanine made by synthesis or fermentation is, and an authorisation attempt for that route was closed without approval in 2022. Confirm your material’s source before committing to a market.
4. Is the sleep evidence free of industry involvement?
Not entirely. The 2019 trial cited above was funded by an L-theanine producer, whose employees co-authored it. We disclose this rather than hide it.
5. What can stop a Japanese factory making my L-theanine product?
Usually a companion botanical in a relaxation or sleep formula. Every ingredient must be permitted in foods in Japan, so we check the full formula first.
Sources: “The effects of L-theanine consumption on sleep outcomes: A systematic review and meta-analysis”, Sleep Medicine Reviews 2025 (PMID 40056718); “Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial”, Nutrients 2019 (PMC6836118, PMID 31623400, DOI 10.3390/nu11102362); Consumer Affairs Agency notifications for Foods with Function Claims; European Commission Novel Food documentation on L-theanine (application NF/2021/2319, procedure terminated 2022) and EU Novel Food status catalogue guidance on green-tea-derived versus synthesised/fermented L-theanine. Checked on 25 September 2026.